- Home
- LDI vs FDMT Comparison
LDI vs FDMT Comparison
Compare LDI & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- FDMT
- Stock Information
- Founded
- LDI 2010
- FDMT 2013
- Country
- LDI United States
- FDMT United States
- Employees
- LDI N/A
- FDMT N/A
- Industry
- LDI Finance: Consumer Services
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- LDI Finance
- FDMT Health Care
- Exchange
- LDI Nasdaq
- FDMT Nasdaq
- Market Cap
- LDI 221.2M
- FDMT 192.2M
- IPO Year
- LDI 2021
- FDMT 2020
- Fundamental
- Price
- LDI $1.29
- FDMT $4.15
- Analyst Decision
- LDI Sell
- FDMT Buy
- Analyst Count
- LDI 3
- FDMT 10
- Target Price
- LDI $1.98
- FDMT $32.33
- AVG Volume (30 Days)
- LDI 1.3M
- FDMT 483.9K
- Earning Date
- LDI 08-05-2025
- FDMT 08-07-2025
- Dividend Yield
- LDI N/A
- FDMT N/A
- EPS Growth
- LDI N/A
- FDMT N/A
- EPS
- LDI N/A
- FDMT N/A
- Revenue
- LDI $1,090,719,000.00
- FDMT $23,000.00
- Revenue This Year
- LDI $28.75
- FDMT $13,048.65
- Revenue Next Year
- LDI $15.05
- FDMT N/A
- P/E Ratio
- LDI N/A
- FDMT N/A
- Revenue Growth
- LDI 21.07
- FDMT N/A
- 52 Week Low
- LDI $1.01
- FDMT $2.24
- 52 Week High
- LDI $3.23
- FDMT $28.93
- Technical
- Relative Strength Index (RSI)
- LDI 46.23
- FDMT 54.29
- Support Level
- LDI $1.22
- FDMT $3.73
- Resistance Level
- LDI $1.45
- FDMT $4.13
- Average True Range (ATR)
- LDI 0.10
- FDMT 0.29
- MACD
- LDI -0.02
- FDMT -0.06
- Stochastic Oscillator
- LDI 13.64
- FDMT 50.00
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.